« Previous
Next »
Seminars in Radiation Oncology
Volume 16, Issue 2
, Pages 67-76
, April 2006
Stereotactic Body Radiation Therapy for Extracranial Oligometastases: Does the Sword Have a Double Edge?
References
- Cancer Statistics, 2005 . CA Cancer J Clin . 2005;55:10–30
- Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer (Analysis of 1001 consecutive cases) . Ann Surg . 1999;230:309–318
- Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer . J Clin Oncol . 1996;14:2197–2205
- Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studies . Cancer . 1990;66:1621–1629
- . Stereotactic body radiation therapy (An ablative treatment option for primary and secondary liver tumors) . Ann Surg Oncol . 2004;11:130–138
- Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) . Int J Radiat Oncol Biol Phys . 1999;45(2):323–329
- Radiation-induced pulmonary toxicity (A dose-volume histogram analysis in 201 patients with lung cancer) . Int J Radiat Oncol Biol Phys . 2001;51:650–659
- Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis . Int J Radiat Oncol Biol Phys . 1995;33:455–460
- Radiation pneumonitis as a function of mean lung dose (An analysis of pooled data of 540 patients) . Int J Radiat Oncol Biol Phys . 1998;42:1–9
-
.
Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and role of regional pulmonary perfusion studies in predicting post-radiotherapy pulmonary function before radiotherapy
.
Cancer Treat Symp
. 1985;2:119–130
- Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin’s disease . Int J Radiat Oncol Biol Phys . 1985;11:1925–1931
- Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor β . Int J Radiat Oncol Biol Phys . 2001;50:899–908
- Radiation pneumonitis and early circulatory cytokine markers . Semin Radiat Oncol . 2002;12(suppl 1):26–33
- Optimizing radiation treatment plans for lung cancer using lung perfusion information . Radiother Oncol . 2002;63:165–177
-
Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v3.0), Cancer Therapy Evaluation Program
. 2005;
Available at: http://ctep.cancer.gov/reporting/ctc.html. Accessed August 23
-
Radiation sensitivity of the liver
.
Adv Radiat Biol
. 1990;14:269–311
- Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies . J Clin Oncol . 2000;18:2210–2218
- A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases . Int J Radiat Oncol Biol Phys . 2005;62:1371–1378
- Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator . Acta Oncol . 1995;34:861–870
- Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis . Cancer . 2003;97:2013–2018
-
Radiosurgery for tumors in the body
(Clinical experience using a new method)
.
J Radiosurg
. 1998;1:63–74
- Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients . Cancer . 1998;82:1062–1070
- Stereotactic radiotherapy of targets in lung and liver . Strahlenther Onkol . 2001;177:645–655
- Megavoltage C.T-assisted stereotactic radiosurgery for thoracic tumors (Original research in the treatment of thoracic neoplasms) . Int J Radiat Oncol Biol Phys . 2000;48:449–457
-
Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage 1 nonsmall cell lung carcinomas
.
Cancer
. 2002;95:1547–1553
- Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame . Int J Radiat Oncol Biol Phys . 2002;52:1041–1046
- Stereotactic single-dose radiotherapy of stage I non-small cell lung cancer . Int J Radiat Oncol Biol Phys . 2003;56:335–341
- Extracranial stereotactic radioablation (Results of a phase I study in medically inoperable stage I non-small cell lung cancer) . Chest . 2003;124:1946–1955
- Stereotactic single high dose irradiation of lung tumors under respiratory gating . Radiother Oncol . 2002;63:159–163
- Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung . Lung Cancer . 2003;40:309–315
- Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers . Int J Radiat Oncol Biol Phys . 2003;56:126–135
-
CT-guided stereotactic radiation therapy for stage I non-small cell lung cancers
.
Lung Cancer
. 2003;S243:
Poster 809
- Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer (A 5-year experience) . Int J Radiat Oncol Biol Phys . 2001;51:666–670
- Stereotactic radiosurgery for lung tumors (Preliminary report of a phase I trial) . Ann Thorac Surg . 2003;75:1097–1101
- Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma (Clinical outcomes in 245 subjects in a Japanese multiinstitutional study) . Cancer . 2004;101:1623–1630
- Stereotactic radiotherapy for primary lung cancer and pulmonary metastases (A noninvasive treatment approach in medically inoperable patients) . Int J Radiat Oncol Biol Phys . 2004;60:186–196
-
Feasability of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer
.
J Radiosurg
. 1998;1:233–238
- Stereotactic single-dose radiation therapy of liver tumors (Results of a phase I/II trial) . J Clin Oncol . 2001;19:164–170
- Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors . Int J Radiat Oncol Biol Phys . 2004;58:1114–1120
- Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer . J Clin Oncol . 2002;20:1491–1498
- Oxaliplatin, flourouracil, and luecovorin as adjuvant treatment for colon cancer . N Engl J Med . 2004;350:2343–2351
- Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer . J Clin Oncol . 2000;18:2938–2947
- Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients . J Clin Oncol . 1995;13:210–221
- Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer (An oncopaz cooperative group study) . J Clin Oncol . 2005;23:3104–3111
- Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients . Cancer . 2001;92:1759–1768
-
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis
.
J Clin Oncol
. 1994;1:1458–1467
- Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease . J Clin Oncol . 1999;17:2639–2648
- . Liver ablation therapy . Br J Radiol . 2004;77:713–723
-
.
Radiation Oncology
(Management Decisions)
. New York, NY: Lippincott Williams and Wilkins; 2002;
p 1
PII: S1053-4296(05)00097-4
doi: 10.1016/j.semradonc.2005.12.002
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Radiation Oncology
Volume 16, Issue 2
, Pages 67-76
, April 2006
